- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular adverse effects of newer antidepressants
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 14, Issue 5, Pages 539-551
Publisher
Informa UK Limited
Online
2014-04-17
DOI
10.1586/14737175.2014.908709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Integrated Analysis of the Safety and Tolerability of Desvenlafaxine Compared with Placebo in the Treatment of Major Depressive Disorder
- (2016) Anita H. Clayton et al. CNS SPECTRUMS
- Effect of Citalopram on Agitation in Alzheimer Disease
- (2014) Anton P. Porsteinsson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antidepressant Augmentation With Anti-Inflammatory Agents
- (2014) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study
- (2014) David Bakish et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Levomilnacipran: a newly approved drug for treatment of major depressive disorder
- (2014) Rajnish Mago et al. Expert Review of Clinical Pharmacology
- Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
- (2013) Rajnish Mago et al. CLINICAL DRUG INVESTIGATION
- Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure
- (2013) Andrade Chittaranjan et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Vilazodone lacks proarrhythmogenic potential in healthy participants: a thorough ECG study
- (2013) John Edwards et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
- (2013) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Drug Interactions in the Treatment of Depression in Patients Receiving β-Blocker Drugs
- (2013) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
- (2013) Angelo Sambunaris et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Acute and subacute effects of the selective serotonin–noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels
- (2013) F. Fischer et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Citalopram, QTc Interval Prolongation, and Torsade de Pointes. How Should We Apply the Recent FDA Ruling?
- (2012) W. Victor R. Vieweg et al. AMERICAN JOURNAL OF MEDICINE
- Norepinephrine transporter function and human cardiovascular disease
- (2012) C. Schroeder et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Depression and heart disease in US adults
- (2012) Ashwini Niranjan et al. GENERAL HOSPITAL PSYCHIATRY
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn
- (2012) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Drug Interactions in the Treatment of Depression in Patients With Ischemic Heart Disease
- (2012) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Sibutramine on Cardiovascular Outcome
- (2011) A. J. Scheen DIABETES CARE
- A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
- (2011) Robert H. Howland DRUG SAFETY
- Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis
- (2010) Andrew H. Kemp et al. BIOLOGICAL PSYCHIATRY
- Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding
- (2010) Chittaranjan Andrade et al. JOURNAL OF CLINICAL PSYCHIATRY
- What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology
- (2010) David J Nutt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure
- (2010) Christopher M. O'Connor et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical and ECG Effects of Escitalopram Overdose
- (2009) Freek van Gorp et al. ANNALS OF EMERGENCY MEDICINE
- Electrocardiogram changes and arrhythmias in venlafaxine overdose
- (2009) Geoffrey K. Isbister BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance
- (2009) B Darpo BRITISH JOURNAL OF PHARMACOLOGY
- Serotonin and pulmonary hypertension—from bench to bedside?
- (2009) Margaret R MacLean et al. CURRENT OPINION IN PHARMACOLOGY
- Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety
- (2008) D. Taylor ACTA PSYCHIATRICA SCANDINAVICA
- A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Sustained-Release Bupropion on Blood Pressure in Individuals With Mild Untreated Hypertension
- (2008) Michael E. Thase et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns
- (2008) G. Dubnov-Raz et al. PEDIATRICS
- Clinical Toxicology of Citalopram After Acute Intoxication With the Sole Drug or in Combination With Other Drugs: Overview of 26 Cases
- (2008) Afra Jimmink et al. THERAPEUTIC DRUG MONITORING
- Medically serious adverse effects of newer antidepressants
- (2008) Rajnish Mago et al. Current Psychiatry Reports
- Outcomes after Isolated Mirtazapine (Remeron™) Supratherapeutic Ingestions
- (2007) Frank LoVecchio et al. JOURNAL OF EMERGENCY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started